Literature DB >> 10080519

Halothane as a neuroprotectant during constant stimulation of the perforant path.

M C Walker1, H Perry, F Scaravilli, P N Patsalos, S D Shorvon, J G Jefferys.   

Abstract

PURPOSE: To determine the neuroprotective effects of halothane during constant stimulation of the perforant path.
METHODS: Male Sprague-Dawley rats had electrodes implanted into the perforant path and dentate granule cell layer under halothane anaesthesia (1-2% in oxygen). They were then divided into four groups. In group 1 (n = 9), the perforant path was stimulated at 20 Hz for 2 h under halothane anaesthesia (1-2%). In group 2 (n = 3), the animals were unstimulated but maintained under halothane anaesthesia (1-2%) for 2 h with the electrodes in place. Both groups 1 and 2 had the electrodes removed and were then allowed to recover fully from the anaesthetic. In groups 3 and 4, the electrodes were held in place with dental acrylic. Both of these groups were allowed to recover fully from anaesthesia. In group 3 (n = 3), 24-48 h after recovery from anaesthesia, the perforant path was stimulated at 20 Hz for 2 h. Group 4 (n = 3) received no stimulation. After 14-17 days, the rats were killed, and morphometry and cell counts were performed on the hippocampi from rats in groups 1 and 2.
RESULTS: Cell densities were not significantly different between control (group 2), unstimulated rats, and animals stimulated under halothane anaesthesia (group 1). Stimulation in the unanaesthetised rats resulted in severe neuronal loss in hilus, CA1, and CA3.
CONCLUSIONS: Halothane protects hippocampal neurons against damage induced by constant stimulation of the perforant path.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10080519     DOI: 10.1111/j.1528-1157.1999.tb00718.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  6 in total

1.  Polyunsaturated fatty acids are potent neuroprotectors.

Authors:  I Lauritzen; N Blondeau; C Heurteaux; C Widmann; G Romey; M Lazdunski
Journal:  EMBO J       Date:  2000-04-17       Impact factor: 11.598

Review 2.  [Management of refractory status epilepticus from a neurologic and neuropediatric perspective].

Authors:  B Pohlmann-Eden; U Stephani; I Krägeloh-Mann; B Schmitt; U Brandl; M Holtkamp
Journal:  Nervenarzt       Date:  2007-08       Impact factor: 1.214

3.  Plasticity of GABA(B) receptor-mediated heterosynaptic interactions at mossy fibers after status epilepticus.

Authors:  Kate E Chandler; Alessandra P Princivalle; Ruth Fabian-Fine; Norman G Bowery; Dimitri M Kullmann; Matthew C Walker
Journal:  J Neurosci       Date:  2003-12-10       Impact factor: 6.167

Review 4.  Mechanisms of physiological and epileptic HFO generation.

Authors:  John G R Jefferys; Liset Menendez de la Prida; Fabrice Wendling; Anatol Bragin; Massimo Avoli; Igor Timofeev; Fernando H Lopes da Silva
Journal:  Prog Neurobiol       Date:  2012-03-07       Impact factor: 11.685

5.  Synaptic GABA release prevents GABA transporter type-1 reversal during excessive network activity.

Authors:  Leonid Savtchenko; Maria Megalogeni; Dmitri A Rusakov; Matthew C Walker; Ivan Pavlov
Journal:  Nat Commun       Date:  2015-03-23       Impact factor: 14.919

6.  Seizure control by ketogenic diet-associated medium chain fatty acids.

Authors:  Pishan Chang; Nicole Terbach; Nick Plant; Philip E Chen; Matthew C Walker; Robin S B Williams
Journal:  Neuropharmacology       Date:  2012-11-20       Impact factor: 5.250

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.